Credit Suisse’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.91M Sell
125,154
-3,138
-2% -$49.3K ﹤0.01% 1881
2023
Q4
$2.06M Sell
128,292
-6,066
-5% -$84.8K ﹤0.01% 1861
2023
Q3
$1.75M Buy
134,358
+3,440
+3% +$44.7K ﹤0.01% 1908
2023
Q2
$1.67M Buy
130,918
+28,467
+28% +$356K ﹤0.01% 2050
2023
Q1
$1.15M Buy
102,451
+4,081
+4% +$49.5K ﹤0.01% 2239
2022
Q4
$1.3M Buy
98,370
+8,812
+10% +$116K ﹤0.01% 2153
2022
Q3
$1.04M Buy
89,558
+5,288
+6% +$72.5K ﹤0.01% 2313
2022
Q2
$1.24M Buy
84,270
+3,319
+4% +$54.4K ﹤0.01% 2236
2022
Q1
$1.57M Buy
80,951
+644
+0.8% +$11.5K ﹤0.01% 2246
2021
Q4
$1.38M Sell
80,307
-21,254
-21% -$362K ﹤0.01% 3066
2021
Q3
$1.7M Sell
101,561
-5,277
-5% -$78.9K ﹤0.01% 2937
2021
Q2
$1.43M Buy
106,838
+24,569
+30% +$307K ﹤0.01% 3111
2021
Q1
$984K Sell
82,269
-32,105
-28% -$388K ﹤0.01% 3339
2020
Q4
$1.42M Buy
114,374
+21,943
+24% +$237K ﹤0.01% 3082
2020
Q3
$965K Sell
92,431
-39,714
-30% -$505K ﹤0.01% 2958
2020
Q2
$1.85M Buy
132,145
+15,421
+13% +$210K ﹤0.01% 2441
2020
Q1
$1.37M Buy
116,724
+58,972
+102% +$780K ﹤0.01% 2405
2019
Q4
$818K Sell
57,752
-16,407
-22% -$201K ﹤0.01% 3264
2019
Q3
$781K Buy
74,159
+29,504
+66% +$353K ﹤0.01% 3174
2019
Q2
$650K Sell
44,655
-33,597
-43% -$476K ﹤0.01% 3242
2019
Q1
$1.1M Sell
78,252
-39,457
-34% -$639K ﹤0.01% 2819
2018
Q4
$2.05M Buy
117,709
+13,595
+13% +$221K ﹤0.01% 2223
2018
Q3
$1.59M Sell
104,114
-6,628
-6% -$95.4K ﹤0.01% 2526
2018
Q2
$1.53M Sell
110,742
-10,004
-8% -$150K ﹤0.01% 2691
2018
Q1
$2.01M Buy
120,746
+5,865
+5% +$90.5K ﹤0.01% 2418
2017
Q4
$1.63M Sell
114,881
-6,609
-5% -$88.1K ﹤0.01% 2609
2017
Q3
$1.72M Buy
121,490
+46,053
+61% +$609K ﹤0.01% 2674
2017
Q2
$965K Sell
75,437
-20,381
-21% -$256K ﹤0.01% 2725
2017
Q1
$1.33M Sell
95,818
-43,895
-31% -$517K ﹤0.01% 2652
2016
Q4
$1.5M Buy
139,713
+1,997
+1% +$21K ﹤0.01% 2672
2016
Q3
$1.51M Sell
137,716
-15,469
-10% -$181K ﹤0.01% 2595
2016
Q2
$1.61M Buy
153,185
+26,543
+21% +$314K ﹤0.01% 2514
2016
Q1
$1.59M Buy
+126,642
New +$1.39M ﹤0.01% 2376
2015
Q4
Sell
-79,756
Closed -$573K 4288
2015
Q3
$573K Sell
79,756
-101,996
-56% -$1.39M ﹤0.01% 3296
2015
Q2
$3.28M Buy
181,752
+79,388
+78% +$1.36M ﹤0.01% 2127
2015
Q1
$1.61M Sell
102,364
-54,207
-35% -$820K ﹤0.01% 2578
2014
Q4
$2.22M Buy
156,571
+51,847
+50% +$779K ﹤0.01% 2459
2014
Q3
$1.79M Sell
104,724
-82,699
-44% -$1.9M ﹤0.01% 2585
2014
Q2
$5.58M Sell
187,423
-110,091
-37% -$2.64M ﹤0.01% 1859
2014
Q1
$7.42M Sell
297,514
-34,801
-10% -$1.02M 0.01% 1455
2013
Q4
$9.54M Sell
332,315
-20,472
-6% -$599K 0.01% 1315
2013
Q3
$11.6M Sell
352,787
-21,505
-6% -$669K 0.01% 1041
2013
Q2
$11.6M Buy
+374,292
New +$10M 0.01% 1044

Other funds holding INVA

Credit Suisse's INVA Position: Q1 2024 in Review

Credit Suisse reduced its Innoviva (INVA) stake by 2.4% in Q1 2024, selling an estimated $49.3K and leaving 125,154 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

Credit Suisse first reported a position in INVA in Q2 2013 and has held it in 43 quarters since. The position peaked at $11.6M in Q2 2013. 217 funds tracked by Wall St. Rank hold INVA as of Q1 2024.

  • Credit Suisse held 125,154 shares of Innoviva worth $1.91M as of Q1 2024.
  • Credit Suisse sold 3,138 Innoviva shares in Q1 2024, an estimated $49.3K.
  • Innoviva made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1881 holding.
  • Credit Suisse first reported a position in Innoviva in Q2 2013 and has held it in 43 quarters since.
  • Credit Suisse's Innoviva position peaked at $11.6M in Q2 2013.
  • 217 funds tracked by Wall St. Rank held Innoviva as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.